Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Best Practices For Adaptive Trial Designs Continue To Evolve

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

Data Monitoring Committees are one option to look at interim data and implement pre-planned adaptations to clinical trials, but the new duty could conflict with DMC’s safety responsibility, participants at a DIA conference note.

You may also be interested in...

Can Basket Trials Boost Use Of Bayesian Statistics?

Basket trials like NCI-MATCH could show the value of adaptive clinical trial designs based on advanced Bayesian statistics, furthering a goal of the 21st Century Cures draft legislation.

Fulyzaq Review Shows FDA Adapting Smoothly To Adaptive Trial Design

Review documents show that Fulyzaq’s clear, if modest, treatment effect compared to placebo was buttressed by a series of exploratory subgroup analyses suggesting greater efficacy in sicker patients.

Sponsors’ Use Of Adaptive Designs Appears To Be Growing

A Drug Information Association working group survey found 477 studies between Jan. 1, 2008 and Sept. 1, 2011 utilized some type of adaptive design.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts